<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04493528</url>
  </required_header>
  <id_info>
    <org_study_id>A09-M36-18A</org_study_id>
    <nct_id>NCT04493528</nct_id>
  </id_info>
  <brief_title>Needle-free Dental Anesthesia</brief_title>
  <official_title>Needle-free Dental Anesthesia: a Pilot Split-mouth Cross-over Randomized Clinical Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Centre/Research Institute of the McGill University Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MEDICAL INTERNATIONAL TECHNOLOGIES (MIT CANADA) INC.</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McGill University Health Centre/Research Institute of the McGill University Health Centre</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients experience pain and anxiety from traditional needle anesthesia and may avoid&#xD;
      necessary dental treatments. The needle-free liquid jet injection(NFLJI) could solve these&#xD;
      problems. NFLJI delivers drug solutions by creating a micro-thin pressure liquid jet to&#xD;
      penetrate the skin and disperse in the soft tissue. It has many advantages like eliminating&#xD;
      injection pain, needle phobia and needle disposal. However, anesthesia techniques in&#xD;
      dentistry were all developed for needle injection, and they are not very effective for NFLJI.&#xD;
      Moreover, clinical trials of dental anesthesia using NFLJI have shown inconsistent efficacy.&#xD;
&#xD;
      In this study, we aim to compare the clinical efficacy between NFLJI and needle dental&#xD;
      anesthesia in pilot split-mouth cross-over randomized clinical trials, assess the feasibility&#xD;
      to conduct such trial on a larger scale.&#xD;
&#xD;
      Participants will be assigned to one of the following four groups: 1. Infiltration on a&#xD;
      maxillary lateral incisor,2. Inferior alveolar nerve block, 3.Mental nerve block, 4.&#xD;
      Infraorbital nerve block. Each participant will receive one injection with a needle and&#xD;
      another one with NFLJI randomly at the same appointment. A washout period of 1 hour between&#xD;
      two procedures for participants' to forget the previous experience. Needle injection will be&#xD;
      performed according to clinical standards. NFLJI will be performed according to a guideline&#xD;
      developed in our research group. Participants will stay in the clinic until the anesthesia&#xD;
      effect disappear and be followed for one week.&#xD;
&#xD;
      The primary outcome is the efficacy and effect of two anesthesia interventions. The secondary&#xD;
      outcome is the pain and anxiety visual analogue scale before and during injection, taste&#xD;
      preference, and complications. Additionally, patients' overall feelings for two interventions&#xD;
      as well as any barriers to conducting such a trial will be recorded.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    COVID-19&#xD;
  </why_stopped>
  <start_date type="Actual">July 18, 2019</start_date>
  <completion_date type="Anticipated">December 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Randomized split-mouth cross-over clinical trial.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
    <masking_description>Each participant receive two anesthesia methods randomly. Total 8 arms, 4 groups, each group will recruit 6 participants. Incase of drop out, a total of 30 participant will be enrolled.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Dental pulp anesthesia</measure>
    <time_frame>10 minutes after injection.</time_frame>
    <description>Dental pulp anesthesia result is measured by an electric pulp test(EPT), successful anesthesia for dental pulp exhibits an EPT at 80.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Efficacy of dental pulp anesthesia</measure>
    <time_frame>10 minutes after injection.</time_frame>
    <description>The number of sucessful dental pulp anesthesia cases over total number of participants in the group.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to initiation of anesthesia</measure>
    <time_frame>1 minute after injection</time_frame>
    <description>Time to initiation of anesthesia feeling, measured by a simple pinch test using a periodontal probe</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to termination of anesthesia</measure>
    <time_frame>3 hours after injection</time_frame>
    <description>Time to termination of anesthesia feeling, measured by a simple pinch test using a periodontal probe</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline pain level</measure>
    <time_frame>1 minute before injection</time_frame>
    <description>Participants' pain level before receiving the needle or needle-free injection, measured by standard visual analog scale for pain. From 0 to 10, 0 stands for &quot;no pain&quot;, 10 stands for &quot;worst pain&quot;. Higher score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain level during injection</measure>
    <time_frame>10 seconds after the injection</time_frame>
    <description>Participants' pain level when receiving the needle or needle-free injection, measured by standard visual analog scale for pain. From 0 to 10, 0 stands for &quot;no pain&quot;, 10 stands for &quot;worst pain&quot;. Higher score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Baseline anxiety level</measure>
    <time_frame>1 minute before injection</time_frame>
    <description>Participants' anxiety level before receiving the needle or needle-free injection, measured by visual analogue scale for anxiety. From 0 to 10, 0 stands for &quot;&quot;Not at all Anxious&quot;, 10 stands for &quot;Extremely Anxious&quot;. Higher score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anxiety level during injection</measure>
    <time_frame>10 seconds after the injection.</time_frame>
    <description>Participants' anxiety level when receiving the needle or needle-free injection, measured by visual analogue scale for anxiety.From 0 to 10, 0 stands for &quot;&quot;Not at all Anxious&quot;, 10 stands for &quot;Extremely Anxious&quot;. Higher score means a worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Taste preference</measure>
    <time_frame>1 minute after the injection</time_frame>
    <description>Participants' taste preference after needle or needle-free injection, measured by 9-point hedonic scale for measuring food acceptability. From 1 to 9, 1 stands for &quot;dislike extremely&quot;, 5 stands for &quot;neither like or dislike&quot;, 9 stands for &quot;like extremely&quot;. Higher score means a better outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse effect [safety]</measure>
    <time_frame>10 seconds after injection.</time_frame>
    <description>Incidence of adverse effect immediately after aneshesia injection, such as tissue damage, bleeding, hematoma.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of adverse effect during follow-up period[safety]</measure>
    <time_frame>up to 7 days</time_frame>
    <description>Incidence of adverse effect after aneshesia procedure during follow-up period, such as: ulcer, hematoma, discomfort, abnormal feeling, nerve damage.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Participant's feedbacks</measure>
    <time_frame>20 minutes after all procedures.</time_frame>
    <description>Reord participants's feedbacks about the whole trial, such as: overall feelings, preferences,complains.</description>
  </other_outcome>
  <other_outcome>
    <measure>Barriers</measure>
    <time_frame>through study completion, from date of recruitment until the date of last follow-up case complition, an average of 6 month.</time_frame>
    <description>Record possible barriesrs in recruitment,randomization,operation.</description>
  </other_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Anesthesia, Local</condition>
  <condition>Needle Phobia</condition>
  <arm_group>
    <arm_group_label>Needle Infiltration anesthesia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received one needle injection of infiltration anesthesia at left or right upper lateral incisors using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle-free infiltration anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received one NFLJI (needle-free liquid jet injection) of infiltration anesthesia at left or right upper lateral incisors using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle mental nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received one needle injection of mental nerve block at left or right lower premolar region using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle-free mental nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received one NFLJI (needle-free liquid jet injection) of mental nerve block at left or right lower premolar region using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle mandibular nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received one needle injection of mandibular nerve block at left or right mandibular foramen using 2 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle-free mandibular nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received one NFLJI (needle-free liquid jet injection) of mandibular nerve block at left or right mandibular foramen using 2 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle infraorbital nerve block</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients received one needle injection of infraorbital nerve block at left or right canine fossa using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Needle-free infraorbital nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients received one NFLJI (needle-free liquid jet injection) of infraorbital nerve block at left or right canine fossa using 1 ml 2% lidocaine with 1:50,000 epinephrine (xylocaine).</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Meso-Jet, 2% lidocaine(xylocaine)</intervention_name>
    <description>Performing local dental anesthesia using needle-free liquid jet injection with different parameters (pressure, volume, injection technique). Anesthetic agent: 2% lidocaine with 1:100,000 epinephrine, dose: 0.3-2ml.</description>
    <arm_group_label>Needle-free infiltration anesthesia</arm_group_label>
    <arm_group_label>Needle-free infraorbital nerve block</arm_group_label>
    <arm_group_label>Needle-free mandibular nerve block</arm_group_label>
    <arm_group_label>Needle-free mental nerve block</arm_group_label>
    <other_name>needle-free device</other_name>
    <other_name>jet injector</other_name>
    <other_name>NFLJI (Needle-free liquid jet injection system)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Needle,2% lidocaine(xylocaine)</intervention_name>
    <description>Performing local dental anesthesia using syringe and needles, same as regular clinical practice. Anesthestic agent: 2% lidocaine with 1:100,000 epinephrine,dose: 0.3-2ml.</description>
    <arm_group_label>Needle Infiltration anesthesia</arm_group_label>
    <arm_group_label>Needle infraorbital nerve block</arm_group_label>
    <arm_group_label>Needle mandibular nerve block</arm_group_label>
    <arm_group_label>Needle mental nerve block</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age between 18-35 years-old&#xD;
&#xD;
          -  fluent in English&#xD;
&#xD;
          -  cooperate&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  has a history of chronic pain,&#xD;
&#xD;
          -  has a systematic disease,&#xD;
&#xD;
          -  has root canal therapy at the upper lateral incisor/lower posterior teeth region.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Faleh Tamimi, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Faculty of Dentistry</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McGill University Faculty of Dentistry</name>
      <address>
        <city>Montr√©al</city>
        <state>Quebec</state>
        <zip>H2X1G1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 22, 2020</study_first_submitted>
  <study_first_submitted_qc>July 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2020</study_first_posted>
  <last_update_submitted>September 2, 2021</last_update_submitted>
  <last_update_submitted_qc>September 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Centre/Research Institute of the McGill University Health Centre</investigator_affiliation>
    <investigator_full_name>Faleh Tamimi</investigator_full_name>
    <investigator_title>Associate Professor, Accociate Dean</investigator_title>
  </responsible_party>
  <keyword>Needle-free injection</keyword>
  <keyword>Dental anesthesia</keyword>
  <keyword>Infiltration</keyword>
  <keyword>Nerve block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

